GREENFIELD, Ind.--(BUSINESS WIRE)--Jan 3, 2023--

Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023. Jeff Simmons, president and CEO, will represent the company and respond to questions from analysts at 12:45 p.m. ET.

A live audio webcast will be available in the “Events and Presentations” section of Elanco’s investor website. A replay will be available for approximately 30 days.

ABOUT ELANCO

Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we’re driven by our vision of Food and Companionship Enriching life and our Elanco Healthy Purpose™ CSR framework – all to advance the health of animals, people and the planet. Learn more at www.elanco.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20230103005002/en/

CONTACT: Investor Contact: Katy Grissom (317) 273-9248kathryn.grissom@elancoah.com

Media Contact: Colleen Parr Dekker (317) 989-7011colleen_parr_dekker@elancoah.com

KEYWORD: UNITED STATES NORTH AMERICA INDIANA

INDUSTRY KEYWORD: HEALTH CONSUMER AGRICULTURE PETS NATURAL RESOURCES VETERINARY

SOURCE: Elanco Animal Health Incorporated

Copyright Business Wire 2022.

PUB: 01/03/2023 08:00 AM/DISC: 01/03/2023 08:02 AM

http://www.businesswire.com/news/home/20230103005002/en